Financials
- Market Capitalization 25.67 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
14.44
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 481 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 62.25 USD | -0.11% | +0.27% | +7.22% | +67.07% | 27.80 B USD | ||
| 489 | INSM Insmed Incorporated - Common Stock | 123.37 USD | +1.53% | +0.70% | +25.63% | -23.87% | 26.94 B USD | ||
| 510 | BNTX BioNTech SE - American Depositary Shares | 103.62 USD | +1.64% | -6.91% | +13.86% | +2.90% | 24.87 B USD | ||
| 514 | ROIV Roivant Sciences Ltd. - Common Shares | 33.55 USD | -2.81% | -8.53% | +1.12% | +83.23% | 24.23 B USD |